Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03844269 · ClinicalTrials.gov registry record · NA

Electroencephalogram (EEG) Study of Inattention Following Treatment With AKL-T01

A NA study of Attention Deficit Hyperactivity Disorder, sponsored by Akili Interactive Labs.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT03844269 is a NA study of Attention Deficit Hyperactivity Disorder that has completed, run by Akili Interactive Labs. The registered enrollment target is 28 participants, below the 206-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03844269, a NA study of Attention Deficit Hyperactivity Disorder, has completed, sponsored by Akili Interactive Labs.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

This study is a single arm, open-label, pilot study to assess midline frontal theta (MFT) power as measured by stimulus-locked electroencephalogram (EEG) before and after treatment with AKL-T01 for improving attention in pediatric participants ages 8-12 years old with attention deficit hyperactivity disorder (ADHD).

Conditions Studied

Attention Deficit Hyperactivity Disorder

Interventions

  • DEVICE AKL-T01

Study Locations (1)

California

  • Cortica Healthcare - San Rafael

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2019-05-10
Est. Completion 2020-02-01
Phase NA

Sponsor

Akili Interactive Labs

13 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03844269

The ClinicalTrials.gov registry entry for NCT03844269 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 206-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (86% lower). The listed sponsor is Akili Interactive Labs, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 1 intervention - of which AKL-T01 is the first listed.

NCT03844269 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03844269 about?

NCT03844269 is a clinical study titled "Electroencephalogram (EEG) Study of Inattention Following Treatment With AKL-T01". This study is a single arm, open-label, pilot study to assess midline frontal theta (MFT) power as measured by stimulus-locked electroencephalogram (EEG) before and after treatment with AKL-T01 for improving attention in pediatric participants ages 8-12 years old with attention deficit hyperactivity...

What is the current status of trial NCT03844269?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2019-05-10. Estimated completion is 2020-02-01.

What conditions does trial NCT03844269 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.

What interventions are being tested in trial NCT03844269?

The interventions under investigation include: AKL-T01 (DEVICE).

Who is sponsoring clinical trial NCT03844269?

This trial is sponsored by Akili Interactive Labs, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03844269 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Attention Deficit Hyperactivity Disorder

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.